+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids



Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids



Drug Delivery 22(5): 652-665



CONTEXTS: Artemisinins and its derivatives are considered the basis in the treatment of Plasmodium falciparum malaria due to their high potency and rapid action. However, they have short half life, low solubility, and poor oral bioavailability, hence the need to formulate sustained release lipid particulate dosage form of these drugs. To formulate and evaluate artesunate-loaded solid lipid microparticles (SLMs) based on structured lipid matrices consisting of soybean oil and dika wax. The lipid matrices were characterized by differential scanning calorimetry (DSC), small-angle X-ray diffraction (SAXD), and wide-angle X-ray diffraction (WAXD). The SLMs were prepared by hot melt-homogenization. Time-dependent particle size analysis, time-dependent pH stability studies, encapsulation efficiency (EE%), and in vitro drug release were carried out on the SLMs. In vivo anti-malarial studies were performed using a modified Peter's 4-day suppressive protocol using Plasmodium berghei infected mice. Thermograms of the lipid matrices showed modifications in the microstructure of dika wax as a result of inclusion of soybean oil. SAXD and WAXD diffractograms showed that the lipid matrices were found to be non-lamellar. Particle size of SLM increased with time, while the pH was almost constant. The SLMs had maximum EE% of 80.6% and sustained the release of artesunate more than the reference tablet. In vivo pharmacodynamic studies showed that the SLMs had significant (p < 0.05) reduction in parasitaemia compared with reference tablet. Artesunate-loaded SLMs could be used once daily in the treatment of malaria.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053288353

Download citation: RISBibTeXText

PMID: 24479677

DOI: 10.3109/10717544.2014.881633


Related references

Formulation of novel sustained release rifampicin-loaded solid lipid microparticles based on structured lipid matrices from Moringa oleifera. Pharmaceutical Development and Technology 20(5): 546-554, 2015

Formulation and Evaluation of Novel Solid Lipid Microparticles for the Sustained Release of Ofloxacin. Pharmaceutical Nanotechnology 5(4): 329-341, 2017

Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride. Drug Delivery 20(3-4): 102-111, 2014

Formulation and evaluation of verapamil hydrochloride loaded solid lipid microparticles. Die Pharmazie 66(1): 24-30, 2011

Formulation, in vitro and in vivo evaluation of halofantrine-loaded solid lipid microparticles. Pharmaceutical Development and Technology 20(8): 941-948, 2015

Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer. Artificial Cells Nanomedicine and Biotechnology 47(1): 957-967, 2019

Preparation and in vitro evaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy. Journal of Microencapsulation 29(3): 225-233, 2012

Development and evaluation of sustained-release clonidine-loaded PLGA microparticles. International Journal of Pharmaceutics 437(1-2): 20-28, 2012

Sustained-release diclofenac potassium-loaded solid lipid microparticle based on solidified reverse micellar solution: in vitro and in vivo evaluation. Journal of Microencapsulation 30(4): 335-345, 2013

Furosemide Loaded Silica-Lipid Hybrid Microparticles: Formulation Development, in vitro and ex vivo Evaluation. Advanced Pharmaceutical Bulletin 5(3): 403-409, 2015

In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide. European Journal of Pharmaceutics and Biopharmaceutics 142: 315-321, 2019

Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics. International Journal of Pharmaceutics 521(1-2): 73-83, 2017

Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables. Journal of Microencapsulation 27(7): 609-617, 2010

Development of Plga microparticles with high immunoglobulin G-loaded levels and sustained-release properties obtained by spray-drying a water-in-oil emulsion. International Journal of Pharmaceutics 566: 291-298, 2019

Sustained release ivermectin-loaded solid lipid dispersion for subcutaneous delivery: in vitro and in vivo evaluation. Drug Delivery 24(1): 622-631, 2017